NOVEMBER 13, 2015 06:19 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2015 EVOTEC HOME CONTACT US CAREERS DOWNLOADS LOADING... ABOUT US OUR SERVICES THERAPEUTIC AREAS PRODUCTS & ALLIANCES SCIENCE POOL INVESTORS TOP STORY Evotec AG reports results of the first nine months of 2015 Hamburg, Germany - 10 November 2015: Evotec AG today reported financial results and corporate updates for the first nine months of 2015. - READ MORE Evotec and Beyond Batten Disease Foundation collaborate to advance emerging therapies to fight juvenile Batten Disease Hamburg, Germany - 20 October 2015: Evotec AG today announced an EVT Execute collaboration with Beyond Batten Disease Foundation ("BBDF") aimed at discovering and developing new treatments for juvenile Batten disease, a rare, fatal autosomal recessive neurodegenerative disorder. - READ MORE Evotec to present at two upcoming IR conferences in November Hamburg, Germany - 11 November 2015: Evotec AG announced today that its CEO, Dr Werner Lanthaler, will present at the Jefferies 2015 Global Healthcare Conference in London, UK, and at the German Equity Forum 2015, Frankfurt, Germany. - READ MORE Request Information Services and Partnering Opportunities Investor Relations/Public Relations Loading weather report... EVENTS NOV 18, 2015 - 2nd Medicinal Chemistry Strategy Meeting USA 2015 - MORE EVENTS NOV 18, 2015 - Jefferies 2015 Global Healthcare Conference - MORE EVENTS Company Presentation November Building integrated and high-value drug discovery alliances 2015-11_Evotec_Company presentation_November NOVEMBER 13, 2015 06:19 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2015 EVOTEC

OCTOBER 11, 2015 09:13 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2015 EVOTEC HOME CONTACT US CAREERS DOWNLOADS LOADING... ABOUT US OUR SERVICES THERAPEUTIC AREAS PRODUCTS & ALLIANCES SCIENCE POOL INVESTORS OUR SERVICES Integrated services Target ID and validation Hit identification Compound management Chemistry Drug metabolism & pharmacokinetics Research informatics & in silico drug discovery Proteomics & metabolomics Cell & protein production In vitro pharmacology In vivo pharmacology Our Services Overview Evotec offers services and alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process. Evotec differentiates itself based on a strong track record in drug discovery, scientists with many years experience in the industry and an innovative technology platform. CATEGORIES Integrated services - READ MORE Target ID and validation - READ MORE Hit identification - READ MORE Compound management - READ MORE Chemistry - READ MORE Drug metabolism & pharmacokinetics - READ MORE Research informatics & in silico drug discovery - READ MORE Proteomics & metabolomics - READ MORE Cell & protein production - READ MORE In vitro pharmacology - READ MORE In vivo pharmacology - READ MORE OCTOBER 11, 2015 09:13 AM CET SEARCH T&C'S DISCLAIMER PRIVACY POLICY IMPRINT RSS ©2015 EVOTEC